Pharmacogenomics is the study of how an individual's genetic makeup influences their response to medications. It combines the fields of pharmacology (the study of drugs) and genomics (the study of genes and their functions) to understand how genetic variations can affect drug efficacy, safety, and dosage requirements.
Pharmacogenomics has the potential to improve patient care, reduce healthcare costs, and enhance drug development processes by identifying patient populations who are most likely to benefit from specific medications. It supports precision medicine approaches, where treatments are tailored to an individual's unique genetic profile, leading to more targeted and effective therapies. However, it's important to note that pharmacogenomic testing is still an evolving field, and its integration into routine clinical practice may vary across healthcare systems. Genetic counseling and healthcare provider expertise are crucial for proper interpretation and application of pharmacogenomic testing results. Apart from a comprehensive collection of drugs and genes, AUGMET has over 20000 unique annotations.